首页> 外文期刊>Human Genetics >Mutations in the calcium-binding motifs of CDH23 and the 35delG mutation in GJB2 cause hearing loss in one family.
【24h】

Mutations in the calcium-binding motifs of CDH23 and the 35delG mutation in GJB2 cause hearing loss in one family.

机译:CDH23的钙结合基序突变和GJB2中的35delG突变导致一个家庭的听力下降。

获取原文
获取原文并翻译 | 示例
       

摘要

We have ascertained a multi-generation family with apparent autosomal recessive non-syndromic childhood hearing loss (DFNB). Failure to demonstrate linkage in a genome-wide scan with 300 polymorphic markers has suggested genetic heterogeneity for the hearing loss in this family. This heterogeneity could be demonstrated by analysis of candidate loci and genes for DFNB. Patients in one branch of the family (branch C) are homozygous for the 35delG mutation in the GJB2 gene (DFNB1). Patients in two other branches (A and B) carry two new mutations in the cadherin 23 ( CDH23) gene (DFNB12). A homozygous CDH23 c.6442G-->A (D2148N) mutation is present in branch A. Patients in branch B are compound heterozygous for this mutation and the c.4021G-->A (D1341N) mutation. The substituted aspartic acid residues are highly conserved and are part of the calcium-binding sites of the extracellular cadherin (EC) domains. Molecular modeling of the mutated EC domains of CDH23 based on the structure of E-cadherin indicates that calcium-binding is impaired. In addition, other aspartic and glutamic acid residue substitutions in the highly conserved calcium-binding sites reported to cause DFNB12 are also likely to result in a decreased affinity for calcium. Since calcium provides rigidity to the elongated structure of cadherin molecules enabling homophilic lateral interaction, these mutations are likely to impair interactions of CDH23 molecules either with CDH23 or with other proteins. DFNB12 is the first human disorder that can be attributed to inherited missense mutations in the highly conserved residues of the extracellular calcium-binding domain of a cadherin.
机译:我们确定了一个多代家庭,患有明显的常染色体隐性遗传性非综合征性儿童听力损失(DFNB)。未能在300个多态性标记的全基因组扫描中显示连锁关系,表明该家族听力损失的遗传异质性。这种异质性可以通过分析DFNB的候选基因座和基因来证明。该家族一个分支(C分支)的患者对GJB2基因(DFNB1)中的35delG突变是纯合的。其他两个分支(A和B)的患者在钙粘着蛋白23(CDH23)基因(DFNB12)中携带两个新突变。分支A中存在纯合CDH23 c.6442G-> A(D2148N)突变。分支B中的患者对该突变和c.4021G-> A(D1341N)突变具有复合杂合性。取代的天冬氨酸残基是高度保守的,并且是细胞外钙粘蛋白(EC)域的钙结合位点的一部分。基于E-钙粘蛋白的结构的CDH23突变EC域的分子模型表明钙结合受损。另外,据报道引起DFNB12的高度保守的钙结合位点中的其他天冬氨酸和谷氨酸残基取代也可能导致对钙的亲和力降低。由于钙为钙粘蛋白分子的拉长结构提供了刚性,从而实现了同源的横向相互作用,因此这些突变可能会削弱CDH23分子与CDH23或与其他蛋白质的相互作用。 DFNB12是第一种人类疾病,可归因于钙黏着蛋白细胞外钙结合结构域高度保守的残基中的遗传错义突变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号